We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Wearable Vacuum Pump Reduces Seroma Risk

By HospiMedica International staff writers
Posted on 12 Jul 2018
A low-profile, user friendly, wearable pump applies sustained vacuum to a closed wound following surgery to remove fluid effectively.

The Somavac Medical Solutions (Memphis, TN, USA) SOMAVAC 100 is a battery-powered device that provides continuous suction to the surgical wound to reduce the risk of seroma. More...
Indicated in a range of surgeries that lead to large surgical flaps that require drains, such as abdominal surgery, mastectomy, plastic surgery, hernia repair, and orthopedic procedures, it is designed to replace the legacy technology of suction bulbs and surgical drains, a solution originally intended for hospital use that can lead to spillage, leakage, and clogging of lines when self-administered.

In addition to its health benefits, the SOMAVAC 100 can be discretely worn under clothing, close to the body, which helps patients return to their normal daily activities while recovering. And while similar in principal to negative pressure wound therapy (NPWT) systems, which apply controlled sub-atmospheric pressure to the local wound environment using a sealed wound dressing connected to a vacuum pump, the SOMAVAC 100 can provide much higher drainage volumes, since NPWT systems are intended for smaller fluid build-up, such as in burns.

“This FDA clearance represents a critical milestone for Somavac Medical Solutions and provides a meaningful advancement in post-surgical care, offering patients the opportunity to recover with dignity at home after major surgeries,” said biomedical engineer Esra Roan, PhD, CEO of Somavac Medical Solutions. “We are excited about receiving our clearance from the FDA for this device so that our technology can begin to improve patients’ recovery after surgeries.”

Seroma is a common postoperative result following ventral hernia repair, with an incidence rate of 20%. Suction using manually operated closed systems has been the mainstay of seroma management for the last 40 years; such devices draw fluid using a compressible suction bulb attached to the end of the drain, which is worn by patients anywhere from days to several months, depending on fluid volume. Inability of the bulb to generate a continuous suction is a major factor in the prolonged drain indwelling times, increasing opportunity for complications.

Related Links:
Somavac Medical Solutions


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Shoulder System
Identity Shoulder System
New
Measuring Rod
seca 233
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: These images show how treatment is impacted by the new TBI framework (Photo courtesy of UCSF)

New System Combines Biomarkers, Imaging and Modifiers for Accurate TBI Diagnosis

In the United States, traumatic brain injury (TBI) led to around 70,000 fatalities in 2021 and contributes to about half a million cases of permanent disability each year. Common causes include motor vehicle... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.